A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome
Clinical trial NCT05673993 · COMPLETED
Trial details
- NCT number
- NCT05673993
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-06
- Primary completion
- 2024-10-29
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.